nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicyclomine—CYP1A1—Dacarbazine—muscle cancer	0.669	1	CbGbCtD
Dicyclomine—Tachyarrhythmia—Doxorubicin—muscle cancer	0.0114	0.0343	CcSEcCtD
Dicyclomine—Speech impairment NOS—Methotrexate—muscle cancer	0.011	0.0331	CcSEcCtD
Dicyclomine—Paralysis—Vincristine—muscle cancer	0.0071	0.0215	CcSEcCtD
Dicyclomine—Necrosis—Dactinomycin—muscle cancer	0.00704	0.0213	CcSEcCtD
Dicyclomine—Numbness—Vincristine—muscle cancer	0.00595	0.018	CcSEcCtD
Dicyclomine—Sensory loss—Vincristine—muscle cancer	0.0057	0.0172	CcSEcCtD
Dicyclomine—Drug hypersensitivity—Doxorubicin—muscle cancer	0.00515	0.0156	CcSEcCtD
Dicyclomine—Necrosis—Etoposide—muscle cancer	0.00509	0.0154	CcSEcCtD
Dicyclomine—Tingling sensation—Etoposide—muscle cancer	0.00497	0.015	CcSEcCtD
Dicyclomine—Numbness—Etoposide—muscle cancer	0.00482	0.0146	CcSEcCtD
Dicyclomine—Apnoea—Etoposide—muscle cancer	0.00472	0.0143	CcSEcCtD
Dicyclomine—Sensory loss—Etoposide—muscle cancer	0.00461	0.0139	CcSEcCtD
Dicyclomine—Lethargy—Dactinomycin—muscle cancer	0.00409	0.0124	CcSEcCtD
Dicyclomine—Paralysis—Methotrexate—muscle cancer	0.00345	0.0104	CcSEcCtD
Dicyclomine—Urinary retention—Vincristine—muscle cancer	0.00341	0.0103	CcSEcCtD
Dicyclomine—Muscular weakness—Vincristine—muscle cancer	0.00316	0.00955	CcSEcCtD
Dicyclomine—Necrosis—Methotrexate—muscle cancer	0.00305	0.00922	CcSEcCtD
Dicyclomine—Paralysis—Doxorubicin—muscle cancer	0.00298	0.00902	CcSEcCtD
Dicyclomine—Thrombosis—Doxorubicin—muscle cancer	0.00293	0.00885	CcSEcCtD
Dicyclomine—Erectile dysfunction—Vincristine—muscle cancer	0.00285	0.00862	CcSEcCtD
Dicyclomine—Apnoea—Methotrexate—muscle cancer	0.00282	0.00854	CcSEcCtD
Dicyclomine—Dermatitis atopic—Doxorubicin—muscle cancer	0.0028	0.00847	CcSEcCtD
Dicyclomine—Speech disorder—Methotrexate—muscle cancer	0.00278	0.00841	CcSEcCtD
Dicyclomine—Necrosis—Doxorubicin—muscle cancer	0.00264	0.00798	CcSEcCtD
Dicyclomine—Ageusia—Doxorubicin—muscle cancer	0.00256	0.00773	CcSEcCtD
Dicyclomine—Hypoaesthesia—Vincristine—muscle cancer	0.00247	0.00745	CcSEcCtD
Dicyclomine—Hallucination—Vincristine—muscle cancer	0.00247	0.00745	CcSEcCtD
Dicyclomine—Erythema—Dactinomycin—muscle cancer	0.00241	0.0073	CcSEcCtD
Dicyclomine—Delirium—Doxorubicin—muscle cancer	0.00241	0.00729	CcSEcCtD
Dicyclomine—Cardiac disorder—Vincristine—muscle cancer	0.0023	0.00695	CcSEcCtD
Dicyclomine—Ill-defined disorder—Dactinomycin—muscle cancer	0.00224	0.00677	CcSEcCtD
Dicyclomine—Mediastinal disorder—Vincristine—muscle cancer	0.00223	0.00675	CcSEcCtD
Dicyclomine—Dyskinesia—Doxorubicin—muscle cancer	0.00221	0.00667	CcSEcCtD
Dicyclomine—Malaise—Dactinomycin—muscle cancer	0.00218	0.00658	CcSEcCtD
Dicyclomine—Mental disorder—Vincristine—muscle cancer	0.00217	0.00656	CcSEcCtD
Dicyclomine—Injection site reaction—Doxorubicin—muscle cancer	0.00206	0.00623	CcSEcCtD
Dicyclomine—Discomfort—Dactinomycin—muscle cancer	0.00203	0.00614	CcSEcCtD
Dicyclomine—Thrombophlebitis—Methotrexate—muscle cancer	0.00201	0.00607	CcSEcCtD
Dicyclomine—Hypoaesthesia—Etoposide—muscle cancer	0.002	0.00604	CcSEcCtD
Dicyclomine—Agitation—Vincristine—muscle cancer	0.00198	0.00599	CcSEcCtD
Dicyclomine—Oedema—Dactinomycin—muscle cancer	0.00197	0.00596	CcSEcCtD
Dicyclomine—Anorexia—Dactinomycin—muscle cancer	0.00188	0.00568	CcSEcCtD
Dicyclomine—Eye disorder—Etoposide—muscle cancer	0.00188	0.00567	CcSEcCtD
Dicyclomine—Cardiac disorder—Etoposide—muscle cancer	0.00186	0.00563	CcSEcCtD
Dicyclomine—Hypertension—Vincristine—muscle cancer	0.00186	0.00563	CcSEcCtD
Dicyclomine—Immune system disorder—Etoposide—muscle cancer	0.00181	0.00548	CcSEcCtD
Dicyclomine—Mediastinal disorder—Etoposide—muscle cancer	0.00181	0.00547	CcSEcCtD
Dicyclomine—Lethargy—Methotrexate—muscle cancer	0.00177	0.00536	CcSEcCtD
Dicyclomine—Anaphylactic shock—Vincristine—muscle cancer	0.00176	0.00532	CcSEcCtD
Dicyclomine—Oedema—Vincristine—muscle cancer	0.00176	0.00532	CcSEcCtD
Dicyclomine—Thrombophlebitis—Doxorubicin—muscle cancer	0.00174	0.00525	CcSEcCtD
Dicyclomine—Nervous system disorder—Vincristine—muscle cancer	0.00173	0.00522	CcSEcCtD
Dicyclomine—Decreased appetite—Dactinomycin—muscle cancer	0.00171	0.00518	CcSEcCtD
Dicyclomine—Fatigue—Dactinomycin—muscle cancer	0.0017	0.00513	CcSEcCtD
Dicyclomine—Pain—Dactinomycin—muscle cancer	0.00169	0.00509	CcSEcCtD
Dicyclomine—Anorexia—Vincristine—muscle cancer	0.00168	0.00507	CcSEcCtD
Dicyclomine—Mood swings—Methotrexate—muscle cancer	0.00165	0.00498	CcSEcCtD
Dicyclomine—Feeling abnormal—Dactinomycin—muscle cancer	0.00162	0.00491	CcSEcCtD
Dicyclomine—Ill-defined disorder—Etoposide—muscle cancer	0.00162	0.0049	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00161	0.00487	CcSEcCtD
Dicyclomine—Insomnia—Vincristine—muscle cancer	0.00159	0.00481	CcSEcCtD
Dicyclomine—Paraesthesia—Vincristine—muscle cancer	0.00158	0.00478	CcSEcCtD
Dicyclomine—Malaise—Etoposide—muscle cancer	0.00158	0.00476	CcSEcCtD
Dicyclomine—Breast disorder—Methotrexate—muscle cancer	0.00157	0.00475	CcSEcCtD
Dicyclomine—Abdominal pain—Dactinomycin—muscle cancer	0.00156	0.00471	CcSEcCtD
Dicyclomine—Loss of consciousness—Etoposide—muscle cancer	0.00154	0.00464	CcSEcCtD
Dicyclomine—Lethargy—Doxorubicin—muscle cancer	0.00154	0.00464	CcSEcCtD
Dicyclomine—Decreased appetite—Vincristine—muscle cancer	0.00153	0.00463	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Vincristine—muscle cancer	0.00152	0.00459	CcSEcCtD
Dicyclomine—Fatigue—Vincristine—muscle cancer	0.00152	0.00459	CcSEcCtD
Dicyclomine—Hypertension—Etoposide—muscle cancer	0.00151	0.00456	CcSEcCtD
Dicyclomine—Constipation—Vincristine—muscle cancer	0.00151	0.00455	CcSEcCtD
Dicyclomine—Pain—Vincristine—muscle cancer	0.00151	0.00455	CcSEcCtD
Dicyclomine—Diplopia—Doxorubicin—muscle cancer	0.00151	0.00455	CcSEcCtD
Dicyclomine—Affect lability—Doxorubicin—muscle cancer	0.00148	0.00448	CcSEcCtD
Dicyclomine—Discomfort—Etoposide—muscle cancer	0.00147	0.00444	CcSEcCtD
Dicyclomine—Face oedema—Doxorubicin—muscle cancer	0.00145	0.00439	CcSEcCtD
Dicyclomine—Hypersensitivity—Dactinomycin—muscle cancer	0.00145	0.00439	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Vincristine—muscle cancer	0.00144	0.00435	CcSEcCtD
Dicyclomine—Confusional state—Etoposide—muscle cancer	0.00144	0.00435	CcSEcCtD
Dicyclomine—Anaphylactic shock—Etoposide—muscle cancer	0.00143	0.00431	CcSEcCtD
Dicyclomine—Mood swings—Doxorubicin—muscle cancer	0.00143	0.00431	CcSEcCtD
Dicyclomine—Asthenia—Dactinomycin—muscle cancer	0.00141	0.00427	CcSEcCtD
Dicyclomine—Tachycardia—Etoposide—muscle cancer	0.00139	0.00421	CcSEcCtD
Dicyclomine—Abdominal pain—Vincristine—muscle cancer	0.00139	0.00421	CcSEcCtD
Dicyclomine—Erectile dysfunction—Methotrexate—muscle cancer	0.00138	0.00418	CcSEcCtD
Dicyclomine—Breast disorder—Doxorubicin—muscle cancer	0.00136	0.00411	CcSEcCtD
Dicyclomine—Anorexia—Etoposide—muscle cancer	0.00136	0.00411	CcSEcCtD
Dicyclomine—Drowsiness—Methotrexate—muscle cancer	0.00134	0.00405	CcSEcCtD
Dicyclomine—Muscular weakness—Doxorubicin—muscle cancer	0.00133	0.00401	CcSEcCtD
Dicyclomine—Abdominal distension—Doxorubicin—muscle cancer	0.00131	0.00396	CcSEcCtD
Dicyclomine—Hypersensitivity—Vincristine—muscle cancer	0.0013	0.00392	CcSEcCtD
Dicyclomine—Paraesthesia—Etoposide—muscle cancer	0.00128	0.00387	CcSEcCtD
Dicyclomine—Dyspnoea—Etoposide—muscle cancer	0.00127	0.00384	CcSEcCtD
Dicyclomine—Somnolence—Etoposide—muscle cancer	0.00127	0.00383	CcSEcCtD
Dicyclomine—Asthenia—Vincristine—muscle cancer	0.00126	0.00382	CcSEcCtD
Dicyclomine—Vomiting—Dactinomycin—muscle cancer	0.00125	0.00379	CcSEcCtD
Dicyclomine—Rash—Dactinomycin—muscle cancer	0.00124	0.00376	CcSEcCtD
Dicyclomine—Decreased appetite—Etoposide—muscle cancer	0.00124	0.00375	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Etoposide—muscle cancer	0.00123	0.00372	CcSEcCtD
Dicyclomine—Fatigue—Etoposide—muscle cancer	0.00123	0.00372	CcSEcCtD
Dicyclomine—Constipation—Etoposide—muscle cancer	0.00122	0.00369	CcSEcCtD
Dicyclomine—Pain—Etoposide—muscle cancer	0.00122	0.00369	CcSEcCtD
Dicyclomine—Feeling abnormal—Etoposide—muscle cancer	0.00118	0.00355	CcSEcCtD
Dicyclomine—Nausea—Dactinomycin—muscle cancer	0.00117	0.00354	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Etoposide—muscle cancer	0.00117	0.00352	CcSEcCtD
Dicyclomine—Dizziness—Vincristine—muscle cancer	0.00116	0.00352	CcSEcCtD
Dicyclomine—Drowsiness—Doxorubicin—muscle cancer	0.00116	0.00351	CcSEcCtD
Dicyclomine—Urticaria—Etoposide—muscle cancer	0.00113	0.00342	CcSEcCtD
Dicyclomine—Abdominal pain—Etoposide—muscle cancer	0.00113	0.00341	CcSEcCtD
Dicyclomine—Eye disorder—Methotrexate—muscle cancer	0.00112	0.0034	CcSEcCtD
Dicyclomine—Vomiting—Vincristine—muscle cancer	0.00112	0.00338	CcSEcCtD
Dicyclomine—Cardiac disorder—Methotrexate—muscle cancer	0.00112	0.00337	CcSEcCtD
Dicyclomine—Rash—Vincristine—muscle cancer	0.00111	0.00336	CcSEcCtD
Dicyclomine—Dermatitis—Vincristine—muscle cancer	0.00111	0.00335	CcSEcCtD
Dicyclomine—Headache—Vincristine—muscle cancer	0.0011	0.00333	CcSEcCtD
Dicyclomine—Immune system disorder—Methotrexate—muscle cancer	0.00109	0.00328	CcSEcCtD
Dicyclomine—Mediastinal disorder—Methotrexate—muscle cancer	0.00108	0.00328	CcSEcCtD
Dicyclomine—Mental disorder—Methotrexate—muscle cancer	0.00105	0.00318	CcSEcCtD
Dicyclomine—Hypersensitivity—Etoposide—muscle cancer	0.00105	0.00318	CcSEcCtD
Dicyclomine—Erythema—Methotrexate—muscle cancer	0.00105	0.00316	CcSEcCtD
Dicyclomine—Nausea—Vincristine—muscle cancer	0.00105	0.00316	CcSEcCtD
Dicyclomine—Hypoaesthesia—Doxorubicin—muscle cancer	0.00104	0.00313	CcSEcCtD
Dicyclomine—Asthenia—Etoposide—muscle cancer	0.00102	0.00309	CcSEcCtD
Dicyclomine—Pruritus—Etoposide—muscle cancer	0.00101	0.00305	CcSEcCtD
Dicyclomine—Vision blurred—Methotrexate—muscle cancer	0.000986	0.00298	CcSEcCtD
Dicyclomine—Eye disorder—Doxorubicin—muscle cancer	0.000973	0.00294	CcSEcCtD
Dicyclomine—Ill-defined disorder—Methotrexate—muscle cancer	0.000971	0.00294	CcSEcCtD
Dicyclomine—Cardiac disorder—Doxorubicin—muscle cancer	0.000966	0.00292	CcSEcCtD
Dicyclomine—Malaise—Methotrexate—muscle cancer	0.000944	0.00285	CcSEcCtD
Dicyclomine—Dizziness—Etoposide—muscle cancer	0.000943	0.00285	CcSEcCtD
Dicyclomine—Immune system disorder—Doxorubicin—muscle cancer	0.00094	0.00284	CcSEcCtD
Dicyclomine—Mediastinal disorder—Doxorubicin—muscle cancer	0.000938	0.00284	CcSEcCtD
Dicyclomine—Mental disorder—Doxorubicin—muscle cancer	0.000912	0.00276	CcSEcCtD
Dicyclomine—Vomiting—Etoposide—muscle cancer	0.000907	0.00274	CcSEcCtD
Dicyclomine—Erythema—Doxorubicin—muscle cancer	0.000906	0.00274	CcSEcCtD
Dicyclomine—Rash—Etoposide—muscle cancer	0.000899	0.00272	CcSEcCtD
Dicyclomine—Dermatitis—Etoposide—muscle cancer	0.000898	0.00272	CcSEcCtD
Dicyclomine—Headache—Etoposide—muscle cancer	0.000893	0.0027	CcSEcCtD
Dicyclomine—Tension—Doxorubicin—muscle cancer	0.000889	0.00269	CcSEcCtD
Dicyclomine—Discomfort—Methotrexate—muscle cancer	0.00088	0.00266	CcSEcCtD
Dicyclomine—Nervousness—Doxorubicin—muscle cancer	0.00088	0.00266	CcSEcCtD
Dicyclomine—Confusional state—Methotrexate—muscle cancer	0.000861	0.0026	CcSEcCtD
Dicyclomine—Anaphylactic shock—Methotrexate—muscle cancer	0.000854	0.00258	CcSEcCtD
Dicyclomine—Vision blurred—Doxorubicin—muscle cancer	0.000854	0.00258	CcSEcCtD
Dicyclomine—Nausea—Etoposide—muscle cancer	0.000847	0.00256	CcSEcCtD
Dicyclomine—Ill-defined disorder—Doxorubicin—muscle cancer	0.000841	0.00254	CcSEcCtD
Dicyclomine—Nervous system disorder—Methotrexate—muscle cancer	0.000838	0.00253	CcSEcCtD
Dicyclomine—Agitation—Doxorubicin—muscle cancer	0.000833	0.00252	CcSEcCtD
Dicyclomine—Malaise—Doxorubicin—muscle cancer	0.000817	0.00247	CcSEcCtD
Dicyclomine—Anorexia—Methotrexate—muscle cancer	0.000814	0.00246	CcSEcCtD
Dicyclomine—Syncope—Doxorubicin—muscle cancer	0.000813	0.00246	CcSEcCtD
Dicyclomine—Palpitations—Doxorubicin—muscle cancer	0.000801	0.00242	CcSEcCtD
Dicyclomine—Loss of consciousness—Doxorubicin—muscle cancer	0.000797	0.00241	CcSEcCtD
Dicyclomine—Hypertension—Doxorubicin—muscle cancer	0.000782	0.00237	CcSEcCtD
Dicyclomine—Insomnia—Methotrexate—muscle cancer	0.000773	0.00234	CcSEcCtD
Dicyclomine—Paraesthesia—Methotrexate—muscle cancer	0.000767	0.00232	CcSEcCtD
Dicyclomine—Discomfort—Doxorubicin—muscle cancer	0.000762	0.0023	CcSEcCtD
Dicyclomine—Dyspnoea—Methotrexate—muscle cancer	0.000762	0.0023	CcSEcCtD
Dicyclomine—Somnolence—Methotrexate—muscle cancer	0.000759	0.0023	CcSEcCtD
Dicyclomine—Dry mouth—Doxorubicin—muscle cancer	0.000755	0.00228	CcSEcCtD
Dicyclomine—Dyspepsia—Methotrexate—muscle cancer	0.000752	0.00227	CcSEcCtD
Dicyclomine—Confusional state—Doxorubicin—muscle cancer	0.000746	0.00225	CcSEcCtD
Dicyclomine—Decreased appetite—Methotrexate—muscle cancer	0.000743	0.00224	CcSEcCtD
Dicyclomine—Oedema—Doxorubicin—muscle cancer	0.00074	0.00224	CcSEcCtD
Dicyclomine—Anaphylactic shock—Doxorubicin—muscle cancer	0.00074	0.00224	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000738	0.00223	CcSEcCtD
Dicyclomine—Fatigue—Methotrexate—muscle cancer	0.000736	0.00223	CcSEcCtD
Dicyclomine—Pain—Methotrexate—muscle cancer	0.000731	0.00221	CcSEcCtD
Dicyclomine—Shock—Doxorubicin—muscle cancer	0.000728	0.0022	CcSEcCtD
Dicyclomine—Nervous system disorder—Doxorubicin—muscle cancer	0.000725	0.00219	CcSEcCtD
Dicyclomine—Tachycardia—Doxorubicin—muscle cancer	0.000722	0.00218	CcSEcCtD
Dicyclomine—Anorexia—Doxorubicin—muscle cancer	0.000705	0.00213	CcSEcCtD
Dicyclomine—Feeling abnormal—Methotrexate—muscle cancer	0.000704	0.00213	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Methotrexate—muscle cancer	0.000699	0.00211	CcSEcCtD
Dicyclomine—Urticaria—Methotrexate—muscle cancer	0.000679	0.00205	CcSEcCtD
Dicyclomine—Abdominal pain—Methotrexate—muscle cancer	0.000675	0.00204	CcSEcCtD
Dicyclomine—Insomnia—Doxorubicin—muscle cancer	0.000669	0.00202	CcSEcCtD
Dicyclomine—Paraesthesia—Doxorubicin—muscle cancer	0.000664	0.00201	CcSEcCtD
Dicyclomine—Dyspnoea—Doxorubicin—muscle cancer	0.000659	0.00199	CcSEcCtD
Dicyclomine—Somnolence—Doxorubicin—muscle cancer	0.000658	0.00199	CcSEcCtD
Dicyclomine—Dyspepsia—Doxorubicin—muscle cancer	0.000651	0.00197	CcSEcCtD
Dicyclomine—Decreased appetite—Doxorubicin—muscle cancer	0.000643	0.00194	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000639	0.00193	CcSEcCtD
Dicyclomine—Fatigue—Doxorubicin—muscle cancer	0.000638	0.00193	CcSEcCtD
Dicyclomine—Pain—Doxorubicin—muscle cancer	0.000633	0.00191	CcSEcCtD
Dicyclomine—Constipation—Doxorubicin—muscle cancer	0.000633	0.00191	CcSEcCtD
Dicyclomine—Hypersensitivity—Methotrexate—muscle cancer	0.000629	0.0019	CcSEcCtD
Dicyclomine—Asthenia—Methotrexate—muscle cancer	0.000613	0.00185	CcSEcCtD
Dicyclomine—Feeling abnormal—Doxorubicin—muscle cancer	0.00061	0.00184	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000605	0.00183	CcSEcCtD
Dicyclomine—Pruritus—Methotrexate—muscle cancer	0.000604	0.00183	CcSEcCtD
Dicyclomine—Urticaria—Doxorubicin—muscle cancer	0.000588	0.00178	CcSEcCtD
Dicyclomine—Abdominal pain—Doxorubicin—muscle cancer	0.000585	0.00177	CcSEcCtD
Dicyclomine—Dizziness—Methotrexate—muscle cancer	0.000565	0.00171	CcSEcCtD
Dicyclomine—Hypersensitivity—Doxorubicin—muscle cancer	0.000545	0.00165	CcSEcCtD
Dicyclomine—Vomiting—Methotrexate—muscle cancer	0.000543	0.00164	CcSEcCtD
Dicyclomine—Rash—Methotrexate—muscle cancer	0.000539	0.00163	CcSEcCtD
Dicyclomine—Dermatitis—Methotrexate—muscle cancer	0.000538	0.00163	CcSEcCtD
Dicyclomine—Headache—Methotrexate—muscle cancer	0.000535	0.00162	CcSEcCtD
Dicyclomine—Asthenia—Doxorubicin—muscle cancer	0.000531	0.0016	CcSEcCtD
Dicyclomine—Pruritus—Doxorubicin—muscle cancer	0.000523	0.00158	CcSEcCtD
Dicyclomine—Nausea—Methotrexate—muscle cancer	0.000507	0.00153	CcSEcCtD
Dicyclomine—Dizziness—Doxorubicin—muscle cancer	0.000489	0.00148	CcSEcCtD
Dicyclomine—Vomiting—Doxorubicin—muscle cancer	0.00047	0.00142	CcSEcCtD
Dicyclomine—Rash—Doxorubicin—muscle cancer	0.000466	0.00141	CcSEcCtD
Dicyclomine—Dermatitis—Doxorubicin—muscle cancer	0.000466	0.00141	CcSEcCtD
Dicyclomine—Headache—Doxorubicin—muscle cancer	0.000463	0.0014	CcSEcCtD
Dicyclomine—Nausea—Doxorubicin—muscle cancer	0.000439	0.00133	CcSEcCtD
